Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.

@article{RodrguezPerlvarez2013ReducedET,
  title={Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.},
  author={Manuel Rodr{\'i}guez-Per{\'a}lvarez and Emmanuel A Tsochatzis and Mar{\'i}a Carmen Naveas and Giulia Pieri and Carmen Garc{\'i}a-Caparr{\'o}s and James O'Beirne and Antonio Poyato-Gonz{\'a}lez and Gustavo Ferr{\'i}n-S{\'a}nchez and Jos{\'e} Luis Montero-{\'A}lvarez and David W. Patch and Douglas Thorburn and Javier Brice{\~n}o and Manuel de la Mata and Andrew K. Burroughs},
  journal={Journal of hepatology},
  year={2013},
  volume={59 6},
  pages={1193-9}
}
BACKGROUND & AIMS Recurrence of hepatocellular carcinoma (HCC) is a major complication after liver transplantation (LT). The initial immunosuppression protocol may influence HCC recurrence, but the optimal regimen is still unknown. METHODS 219 HCC consecutive patients under Milan criteria, who received an LT at 2 European centres between 2000 and 2010, were included. Median follow-up was 51 months (IQR 26-93). Demographic characteristics, HCC features, and immunosuppression protocol within… CONTINUE READING
33 Citations
28 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Similar Papers

Loading similar papers…